Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma.
Sawako Uchida-KobayashiKen KageyamaShigekazu TakemuraKazuhiro MatsumotoNaoshi OdagiriAtsushi JogoKohei KotaniRitsuzo KozukaHiroyuki MotoyamaEtsushi KawamuraAtsushi HagiharaAkira YamamotoHideki FujiiShogo TanakaMasaru EnomotoAkihiro TamoriYukio MikiShoji KuboNorifumi KawadaPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
Rechallenge TACE after LEN is an effective treatment that may result in a favorable prognosis.
Keyphrases